Do you want to read an article? Please log in or register.
Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities
Related content
COPD
Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk
Heart.
Brook RD, Anderson JA, Calverley PM, Celli BR, Crim C, Denvir MA, Magder S, Martinez FJ, Rajagopalan S, Vestbo J, Yates J, Newby DE; SUMMIT Investigators
doi: 10.1136/heartjnl-2016-310897.
COMMENTED
COPD
β-Blockers in COPD: A Cohort Study From the TONADO Research Program
Maltais F, Buhl R, Koch A, Amatto VC, Reid J, Grönke L, Bothner U, Voß F, McGarvey L, Ferguson GT
RECOMMENDED
AsthmaCOPD
Effectiveness and Safety of Inhaled Corticosteroids in Older Individuals with COPD and/or Asthma: A Population Study
Ann Am Thorac Soc.
Kendzerska T, Aaron SD, To T, Licskai C, Stanbrook M, Vozoris N, Hogan ME, Tan WC, Bourbeau J, Gershon AS, Canadian Respiratory Research Network.
doi: 10.1513/AnnalsATS.
RECOMMENDED
COPD
Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Suissa S, Dell'Aniello S, Ernst P
doi: 10.1016/j.rmed.2021.106645
COPD
The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes.
Int J Chron Obstruct Pulmon Dis.
Bosnic-Anticevich S, Chrystyn H, Costello RW, Dolovich MB, Fletcher MJ, Lavorini F, Rodríguez-Roisin R, Ryan D, Wan Yau Ming S, Price DB
doi: 10.2147/COPD.S117196.
RECOMMENDED
COPD
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Day NC, Kumar S, Criner G, Dransfield M, Halpin DMG, Han MK, Jones CE, Kaisermann MC, Kilbride S, Lange P, Lomas DA, Martin N, Martinez FJ, Singh D, Wise R, Lipson DA
doi: 10.1186/s12931-020-01398-w.
RECOMMENDED
Further Publications
Effects of Inhaled Corticosteroid/long-acting beta-2 Agonist Combination on the Airway Microbiome of Patients with COPD: A Randomized Controlled Trial (DISARM)
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med
Leitao Filho FS, Takiguchi H, Akata K, Ra SW, Moon JY, Kim HK, Cho Y, Yamasaki K, Milne S, Yang J, Yang CWT, Li X, Nislow C, van Eeden SF, Shaipanich T, Lam S, Leung JM, Sin DD
doi: 10.1164/rccm.202102-0289OC
RECOMMENDED
COPD
The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD
Eur Respir J.
Singh D, Abbott-Banner K, Bengtsson T, Newman K
doi: 10.1183/13993003.
Further Publications
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of the IMPACT Trial
Chest.
Hanania NA, Mannino DM, Criner GJ, Dransfield MT, Han MK, Jones CE, Kilbride S, Lomas DA, Martin N, Martinez FJ, Singh D, Wise RA, Halpin DMG, Lima R, Lipson DA
doi: 10.1016/j.chest.2020.09.253.